[1]
“Evaluation of the prescription of oral hypoglycemic agents in the adult population with type 2 diabetes mellitus”, Int J Med Surg Sci, vol. 8, no. 2, pp. 1–14, Jan. 2021, doi: 10.32457/ijmss.v8i2.632.